{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research


LIVEBreastHybridConcordant CareIBC
IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research Banner

  • Overview
  • Faculty
  • Schedule
  • Brochure
  • Hotel
  • View Content
  • Exhibitors
  • Register
Add to Calendar IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research 11/13/2025 6:30:00 PM 11/14/2025 7:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/IBCCC2025 Description: Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer with a significantly poorer prognosis compared to other subtypes, due to its rapid progression, high risk of metastasis and relapse, and elevated mortality rate. Despite numerous efforts, no FDA-approved, IBC-specific therapies or diagnostic tools currently exist. As such, there is an urgent need to identify effective therapeutic str... MD Anderson - Duncan Building false MM/DD/YYYY


Date & Location
Thursday, November 13, 2025, 6:30 PM - Friday, November 14, 2025, 7:00 PM, MD Anderson - Duncan Building, Houston, TX

Target Audience
Specialties - ALL
Professions - Nurse - APRN, Nurse - LVN, Nurse - RN, Other, Physician (MD or DO), Physician Associate, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

Overview
Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer with a significantly poorer prognosis compared to other subtypes, due to its rapid progression, high risk of metastasis and relapse, and elevated mortality rate. Despite numerous efforts, no FDA-approved, IBC-specific therapies or diagnostic tools currently exist. As such, there is an urgent need to identify effective therapeutic strategies that can improve patient survival. This two-day meeting will bring together clinical investigators, practicing physicians, basic scientists, patient advocates, and institutions interested in establishing IBC clinics in their regions. The goal is to advance understanding of the disease, promote collaboration, enhance guideline-concordant care, and design community-based trials or data initiatives that directly benefit IBC patients. We anticipate that the insights and partnerships formed during this meeting will lead to measurable improvements in outcomes such as survival and tumor response within the next three years.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Review the current standards of care for diagnosis and treatment of inflammatory breast cancer (IBC), including trends in the decreasing use of some standard approaches.
  2. Discuss ongoing clinical trials in IBC and novel breast cancer treatments, covering both biological insights and operational strategies to foster expanded collaboration across the US.
  3. Examine new concepts from the latest translational research developments related to IBC.
  4. Initiate strategies to translate basic research findings into clinical research or direct patient care.

Registration

Call for Abstracts
Please use the link below to submit your abstract. All submissions will be reviewed, and selected abstracts will be chosen for presentation. Submission deadline ends Monday, September 15, 2025.

IBCCC HYBRID Retreat 2025 – Abstract Submission Form: CLICK HERE

Abstract Formatting Instructions

The IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research will begin on Thursday, November 13, 2025, with a Poster Session and Networking Event, featuring light refreshments, from 6:30 PM to 9:00 PM.

The conference will continue on Friday, November 14, 2025, beginning with Opening Remarks at 8:00 AM and adjourning at 5:00 PM.

Location: This hybrid event will be held in person at the Duncan Building (CPB), 1155 Pressler St., 8th Floor (Rooms 1–8), Houston, TX 77030, with virtual participation also available for remote attendees.

CONFERENCE REGISTRATION FEES:

 

Physicians (MD, DO’s) – In Person

$50

Students/Fellows/Residents/All Others – In Person

$25

 

Physicians (MD, DO’s) - Virtual

$50

Students/Fellows/Residents/All Others – Virtual

$25

 

 

MD Anderson's BOOT WALK Information:

The IBCCC Retreat is scheduled right before the MD Anderson’s Boot Walk to End Cancer event

(Saturday, November 15, 2025)

We warmly invite you to join us and would be honored to have your support for team IBC Wranglers

Join team IBC Wranglers, walk .2 miles

ANYWHERE YOU ARE

  • Registration is Free

  • To join our team, click link below to register:

Join the IBC Wranglers for Boot Walk 2025

If you would like to donate (TAX deductible) to team IBC Wranglers:

  • Please click this link:

Donate to IBC Wranglers for Boot Walk 2025

  • If you are sending a check, PAY TO: MD Anderson Cancer Center, Memo: BWH25 IBC Wranglers, and mail the check to MD Anderson Boot Walk, P.O. Box 4470, Houston, TX 77210

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check (payable to The University of Texas MD Anderson Cancer Center through U.S. banks only)

 

Mail checks to:

     Continuing Professional Education – Unit 1781
     The University of Texas MD Anderson Cancer Center
     P.O. Box 301407
     Houston, TX 77230-1407

Telephone registrations will not be accepted.

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.  Once your payment has been made, a receipt can be found in the MyCE tab of your PEP@MD Anderson account. 

Refund/Cancellation Policy
The registration fee, minus a $25.00 administration-handling fee, is refundable if a written request is 
received on or before Friday, November 7, 2025.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the Department of Continuing Professional Education, is limited to the registration fee. CPE will refund the full registration fee. 
 
The Department of Continuing Professional Education, reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

Special Assistance

For additional information contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]. If you have any ADA accommodation needs or need assistance.

 

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. The survey link will be provided during the review course.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 7.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 


Hotel Options: 

Houston Marriott Medical Center / Museum District
6580 Fannin Street
Houston TX  7030
713-770-8167
Houston Marriott Medical Center / Museum District
Room Rate: Varies

Hilton Houston Plaza/Medical Center
6633 Travis Street
Houston TX  7030
713-313-4000
Hilton Houston Plaza/Medical Center
Room Rate: Varies

DoubleTree by Hilton Houston Medical Center Hotel & Suites
6800 Main Street
Houston, TX  77030
713-528-7744
DoubleTree by Hilton Medical Center
Rom Rate: Varies

Hilton Garden Inn Houston Medical Center
6840 Almeda Rd.
Houston, Texas 77030
346-433-8200
Hilton Garden Inn Houston Medical Center
Rom Rate: Varies

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Huifang Lu, MD, PhD
Professor
MD Anderson Cancer Center
CE Reviewer
Nothing to disclose
Wendy A. Woodward, MD
Professor, Radiation Oncology Department
The University of Texas MD Anderson Cancer Center
Course Director, Faculty
Nothing to disclose
Lindsey J Anstine, PhD
Susan G. Komen
Faculty
Nothing to disclose
Terry Arnold
IBC Network Foundation
Faculty
Nothing to disclose
Rohini Bhatia, MD
Emory University
Faculty
Nothing to disclose
Yee Chung Cheng, MD
Associate Professor
Medical College of Wisconsin
Faculty
Nothing to disclose
Joseph Dayan, MD, MBA
Director, Institute for Lymphatic Surgery & Innovation
The Institute for Advanced Reconstruction
Faculty
Advisor-Stryker (any division)
Gayathri Devi, PhD
Professor
Duke University
Faculty
Nothing to disclose
Rachel Ford, Patient Advocate/Survivor
Patient
Patient
Faculty
Nothing to disclose
Olivia Franz, BA
NA
Faculty
Nothing to disclose
Reshma Jagsi, MD
Lawrence W. Davis Professor
Emory University School of Medicine
Faculty
Advisor-Blue Cross Blue Shield Association
Jerome Jourquin, PhD, MS
Susan G. Komen
Faculty
Nothing to disclose
Virginia Kaklamani, MD
UT Health San Antonio
Faculty
Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Lilly USA, LLC|Consulting Fee-Genentech, Inc.|Consulting Fee-Pfizer Inc.
Jose Leone, MD
Dana-Farber Cancer Institute
Faculty
Grant or research support-Lilly USA, LLC|Grant or research support-Genentech, Inc.|Grant or research support-Kazia Therapeutics (Relationship has ended)|Consulting Fee-Minerva Biotechnologies
Bora Lim, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Gilead Sciences, Inc. (Relationship has ended)
Anthony Lucci, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Filipa Lynce, MD
Dana-Farber Cancer Institute
Faculty
Grant or research support-AstraZeneca US|Grant or research support-Zentalis|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-CytomX (Relationship has ended)|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Incyte Corporation|Advisor-AstraZeneca US|Advisor-Daiichi Sankyo, Inc.|Advisor-Pfizer Inc.
Ginny Mason, BSN
Executive Director
Inflammatory Breast Cancer Research Foundation
Faculty
Nothing to disclose
Brittany Murphy, MD
Banner MD Anderson
Faculty
Nothing to disclose
Faina Nakhlis, MD
Dr
Dana-Farber/Brigham Cancer Center
Faculty
Nothing to disclose
Katrece Nolen, MBA
Independent Consultant
Faculty
Nothing to disclose
Saleh Ramezani, PhD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Pedram Razavi, MD, PhD
Memorial Sloan Kettering Cancer Center
Faculty
Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-AstraZeneca US|Grant or research support-Tempus|Grant or research support-Guardant|Grant or research support-Myriad|Grant or research support-Personalis|Grant or research support-SAGA Diagnostics |Grant or research support-Biodesix|Consulting Fee-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-AstraZeneca US (Relationship has ended)|Consulting Fee-Prelude Therapeutics (Relationship has ended)|Consulting Fee-Regor Pharmaceuticals (Relationship has ended)|Consulting Fee-SAGA Diagnostics|Consulting Fee-Myriad (Relationship has ended)|Consulting Fee-Neogenomics (Relationship has ended)|Advisor-Tempus|Advisor-Lilly USA, LLC|Advisor-Pathos AI|Advisor-Biovica (Relationship has ended)|Consulting Fee-Foresight
Staci L Roe
Patient Advocate
Faculty
Nothing to disclose
Laila Samiian, MD
Breast Surgical Oncologist
Baptist MD Anderson Cancer Center
Faculty
Nothing to disclose
Mark Schaverien, MD
Assistant Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Alisa Shorago, JD
STS
Faculty
Nothing to disclose
Jasmine S. Sukumar, MD
University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Susie X. Sun, MD
UT MD Anderson
Faculty
Nothing to disclose
Mediget Teshome, MD, MPH
UCLA
Faculty
Honoraria-AstraZeneca US (Relationship has ended)
Laura Warren, MD
Dana-Farber Brigham Cancer Center
Faculty
Honoraria-Castle Biosciences, Inc. (Relationship has ended)|Honoraria-Allergan, Inc.
Angela Alexander, PhD
Senior Clinical Studies Coordinator
MD Anderson Cancer Center
Faculty, Planning Committee Member
Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Daiichi Sankyo, Inc. (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)
Zeynep Aydi, MD
Breast Surgical Oncologist
Banner MD Anderson
Faculty, Planning Committee Member
Nothing to disclose
Shakeela Bahadur, MD
Mayo Clinic
Faculty, Planning Committee Member
Nothing to disclose
Julia Laursen, BSN
None
Faculty, Planning Committee Member
Nothing to disclose
Rachel M. Layman, MD
Professor
MD Anderson Cancer Center
Faculty, Planning Committee Member
Grant or research support-Lilly USA, LLC|Grant or research support-Accutar Biotechnology, Inc.|Paid consultant-Lilly USA, LLC (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals Corporation|Paid consultant-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Pfizer Inc.|Grant or research support-Puma|Grant or research support-Celcuity|Paid consultant-Celcuity (Relationship has ended)|Grant or research support-Arvinas|Grant or research support-Biotheryx|Paid consultant-Biotheryx (Relationship has ended)
Ashley Marumoto, MD
Surgeon
University of Hawaii
Faculty, Planning Committee Member
Nothing to disclose
Sadia Saleem, MD
Dr.
MD Anderson
Faculty, Planning Committee Member
Nothing to disclose
Michael C. Stauder, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty, Planning Committee Member
Nothing to disclose
Audree Tadros, MD, MPH
Associate Attending
Memorial Sloan Kettering Cancer Center
Faculty, Planning Committee Member
Nothing to disclose
Liz Beal, MEd
None
Planning Committee Member
Nothing to disclose
Swetha Bopparaju, MD, MBA
Program Director
MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose
Azadeh Nasrazadani, MD
MD Anderson Cancer Center
Planning Committee Member
Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-AstraZeneca US (Relationship has ended)
Marcella Sanchez, AA
Program Coordinator
MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose
Naoto T Ueno, MD, PhD
Director
University of Hawaii Cancer Center
Planning Committee Member
Paid consultant-AstraZeneca US|Paid consultant-Bayer HealthCare Pharmaceuticals, Inc.|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Eisai, Inc.|Paid consultant-Genentech, Inc.|Paid consultant-Genomic Health, Inc.|Paid consultant-Gilead Sciences, Inc.|Paid consultant-Lavender Health, OncoCyte Corporation, Pear Bio, Peptilogics, Inc., Phoenix Molecular Designs,|Speakers Bureau-AstraZeneca US|Speakers Bureau-Daiichi Sankyo, Inc.|Speakers Bureau-Pfizer Inc.|Speakers Bureau-Chugai Roche, Inc.,Kyowa Kirin Co., Ltd., Total Health Conferencing, and Eli Lilly. |Grant or research support-Eisai, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Phoenix Mole, Puma Biotech, Oncolys BioPharma, OBI, ChemDiv, Tolero Pharma,VITRAC Therapeutics
Martha L Van Dam, MS
Living Beyond
Planning Committee Member
Nothing to disclose
Gary J Whitman, MD
Professor, Breast Imaging Department
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Consulting Fee-Siemens Healthineers

Thursday, November 13, 2025
 
Poster Session - (No CE Crredits Awarded)

Combination of a Novel MELK Inhibitor with Standard of Care Treatment Results in Tumor Regression and Improved Survival in a Triple-Negative Inflammatory Breast Cancer Xenograft Model
6:30PM - 6:37PM


Poster Presenter: Mohd Mughees, PhD

 


Aurora Kinase A (AURKA) A New Druggable Target in ER+ Inflammatory Breast Cancer
6:38PM - 6:44PM


Poster Presenter: Tanu Sharma, PhD

 


Characterizing CCR7 Gene Amplification and Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer
6:44PM - 6:51PM


Poster Presenter: Surbhi Shivhare, PhD

 


sEcad–STAT3/NF?B Axis in Inflammatory Breast Cancer Progression
6:51PM - 6:58PM


Poster Presenter: Tesfamariam Kiros Haddish, PhD

 


An Integrative Approach to Improving Outcomes for Inflammatory Breast Cancer (IBC) Patients: Creating a Diagnostic Tool, Advocating for ICD-10-CM Codes, and Establishing a Task Force to Address Critical Research Gaps
6:58PM - 7:05PM


Poster Presenter: Lindsey Anstine, PhD

 


Engaging Breast Cancer Survivors in the United States in Research: Clinical characteristics and Demographics from Susan G. Komen’s ShareForCures® two-year cohort
7:05PM - 7:12PM

Poster Presenter: Jerome Jourquin, PhD

 


Does Surgery in a Specialized Clinic Improve Locoregional Recurrence Rates in Inflammatory Breast Cancer?
7:12PM - 7:19PM


Poster Presenter: Megan McClanahan, MD

 


Increasing Awareness of Inflammatory Breast Cancer within an MD Anderson Network Partner Site
7:19PM - 7:26PM


Poster Presenter: Cynthia Anderson, MD

 


Clinical Correlates and Racial Disparities in Inflammatory Breast Cancer Survival, U.S. 2000-2021 
7:26PM - 7:33PM


Poster Presenter: Kameko Karasaki

 


Poster Session, Networking, and Reception
7:33PM - 9:00PM

Friday, November 14, 2025
Breakfast and Onsite Registration
7:00AM - 8:00AM

 
Session 1: Guideline Concordant Care (GCC)

Moderator(s): Shakeela Bahadur, MD
Welcome Remarks & Introductions
8:00AM - 8:15AM
Wendy A. Woodward, MD

IBC Guideline Concordant Care, National Cancer Database (NCBD)
8:15AM - 8:30AM
Audree Tadros, MD, MPH

IBC Guideline Concordant Care, Surveillance Epidemiology and End Results (SEER)
8:30AM - 8:45AM
Jose Leone, MD


Apologies, but the PowerPoint presentation will not be available for this talk.

 


Surgeon Guideline Self-Reporting
8:45AM - 9:00AM
Mediget Teshome, MD, MPH

Panel Discussion
9:00AM - 9:30AM
Rachel Ford, Patient Advocate/Survivor
Julia Laursen, BSN
Katrece Nolen, MBA

 
Session 2: Evidence & Gaps in IBC Diagnosis and Treatment

Moderator(s): Virginia Kaklamani, MD and Zeynep Aydi, MD
IBC Diagnosis Progress; IBC Score
9:30AM - 9:45AM
Ginny Mason, BSN

Surgery in IBC, Always Modified Radical Mastectomy?
9:45AM - 10:00AM
Faina Nakhlis, MD

Axillary Procedures in IBC, Always Axillary Lymph Node Dissection?
10:00AM - 10:15AM
Ashley Marumoto, MD

Radiation in IBC, Are There Options?
10:15AM - 10:30AM
Michael C. Stauder, MD

Break
10:30AM - 10:45AM

Preventing Lymphedema in IBC
10:45AM - 11:00AM
Mark Schaverien, MD

Grey Zones in Medical Oncology
11:00AM - 11:15AM
Bora Lim, MD

Challenging Cases
11:15AM - 11:45AM
Yee Chung Cheng, MD
Anthony Lucci, MD
Sadia Saleem, MD
Susie X. Sun, MD
Laura Warren, MD
Bora Lim, MD
Brittany Murphy, MD


Moderator: 

Sadia Saleem, MD

 

Case Presenters:

Yee Chung Cheng, MD

Brittany Murphy, MD, MS, FACS

Laila Samiaan, MD

 

Panel:

Susie Sun, MD

Laura Warren, MD, EdM


 
Session 3: Opportunities in Surveillance

Moderator(s): Massimo Cristofanilli, MD
MDACC - Minimal Residual Disease in IBC
11:45AM - 12:00PM
Anthony Lucci, MD

MSKCC - Utilizing Liquid Biopsy in Early-Stage Breast Cancer 
12:00PM - 12:15PM
Pedram Razavi, MD, PhD

GLP-1 Inhibitors for Lymphedema - (No CE Credits Awarded)
12:15PM - 12:30PM
Joseph Dayan, MD, MBA

Lunch - IBC Consensus Update: Patient Education Session
12:30PM - 1:30PM
Ashley Marumoto, MD
Reshma Jagsi, MD
Rohini Bhatia, MD

 
Session 4: Patient Perspectives & Advocacy Opportunities; Considerations for Community Outreach and Rural Practice

Moderator(s): Julia Laursen, RN
Advocate Training Initiatives - Concrete Ways to Get Involved
1:30PM - 1:45PM
Olivia Franz, BA
Staci L Roe
Alisa Shorago, JD

Discussion
1:45PM - 2:15PM

 
Session 5: Building a National IBC Community Trialist Program

Moderator(s): Filipa Lynce, MD and Wendy Woodward, MD
IBC Connect and IBC CLEAR Project Overview
2:15PM - 2:30PM
Sadia Saleem, MD

IBC Clear Data Collection & Workflow
2:30PM - 2:45PM
Angela Alexander, PhD

Artificial Intelligence in IBC
2:45PM - 3:00PM
Saleh Ramezani, PhD

Break
3:00PM - 3:15PM

Potential Pragmatic Trials to Improve Guideline Concordant Care in IBC
3:15PM - 3:30PM
Rachel M. Layman, MD
Anthony Lucci, MD
Audree Tadros, MD, MPH
Laura Warren, MD
Faina Nakhlis, MD

Small Group Breakout Session and Discussion
3:30PM - 4:00PM

IBCCC Planning:
4:00PM - 5:00PM
Wendy A. Woodward, MD
Filipa Lynce, MD
Gayathri Devi, PhD
Lindsey J Anstine, PhD
Jerome Jourquin, PhD, MS
Terry Arnold


  • Komen Breast Cancer Registry, Share For Cures 
  • Opportunities in Community Engagement; Reaching Rural Providers 
  • Role of Advocacy
  • Governance Models; Examples from Existing Trialists’ Groups 


Adjourn - Reception & Informal Networking
5:00PM - 5:05PM

Reception & Informal Networking 5:00 PM - 7:00 PM

 


Disclaimer: By clicking on "Exhibitors" you have left the accredited educational content of the course.

Platinum

Natera, Inc.

Click Here to Visit Company Website


Gold

Artidis, Inc.

Click Here to Visit Company Website

Daiichi Sankyo, Inc.

Click Here to Visit Company Website

Novartis

Click Here to Visit Company Website


Bronze

AstraZeneca

Gilead Sciences, Inc.

Eli Lilly

Merck

Menarini Stemline

Puma Biotechnology



Contact Us:
Robyn P. Davis, MPH, Senior Continuing Education Coordinator, Continuing Education
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
PO Box 301407
Houston, TX 77230-1407
Phone: 346-721-9712
Email: [email protected]


W9 Form Exhibit at this Event

Exhibitor Packages

Exhibitor Package - 1 - Additional Badge Price: $500.00
Includes:
  • Recognition as a 1 - Additional Badge Exhibitor
  • Number of Exhibitor Badges: 1

Deadline for order commitment is 11/15/2025 12:00:00 AM.

Exhibitor Package - 2 - Additional Badges Price: $1000.00
Includes:
  • Recognition as a 2 - Additional Badges Exhibitor
  • Number of Exhibitor Badges: 2

Deadline for order commitment is 11/15/2025 12:00:00 AM.

Exhibitor Package - 3 - Additional Badges Price: $1500.00
Includes:
  • Recognition as a 3 - Additional Badges Exhibitor
  • Number of Exhibitor Badges: 3

Deadline for order commitment is 11/15/2025 12:00:00 AM.

TO JOIN THE CONFERENCE
Click the button below to join the IBCCC Retreat via Zoom:
JOIN CONFERENCE
Join by Phone

Phone one-tap

US: +13462487799,,94108048230# or +12532158782,,94108048230#

Join by Telephone

Dial: US : +1 346 248 7799 or +1 253 215 8782 or +1 669 900 6833 or +1 301 715 8592 or +1 312 626 6799 or +1 929 205 6099 or 877 853 5257 (Toll Free) or 888 475 4499 (Toll Free)

Meeting ID: 941 0804 8230

Passcode: 940287

International numbers

Join from an H.323/SIP room system 

H.323: 144.195.19.161 (US West) ; 206.247.11.121 (US East) ; 115.114.131.7 (India Mumbai) ; 115.114.115.7 (India Hyderabad) ; 159.124.15.191 (Amsterdam Netherlands) ; 159.124.47.249 (Germany) ; 159.124.104.213 (Australia Sydney) ; 159.124.74.212 (Australia Melbourne) ; 170.114.134.121 (Hong Kong SAR) ; 64.211.144.160 (Brazil) ; 159.124.168.213 (Canada Toronto) ; 159.124.196.25 (Canada Vancouver) ; 170.114.194.163 (Japan Tokyo) ; 147.124.100.25 (Japan Osaka)

Meeting ID: 941 0804 8230

Passcode: 940287

SIP: [email protected]

 

Purchase
JOIN Break-Out Session 1 - Surgery
To Join Break-Out Session 1 - Surgery click the link below: 
Join Break-Out Session 1 - Surgery
Join Break-Out Session 2 - Radiotherapy
To Join Break-Out Session 2 - Radiotherapy click the link below: 
Join Break-Out Session 2 - Radiotherapy
JOIN Break-Out Session 3 - Systemic Therapies
To Join Break-Out Session 3 - Systemic Therapies click the link below: 
JOIN Break-Out Session 3 - TBD
JOIN Break-Out Session 4 - Diagnosis and Survivorship
To Join Break-Out Session 4 - Diagnosis and Survivorship click the link below: 
JOIN Break-Out Session 4 - TBD

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram